Metered Dose Inhaler Propellant Transition: US FDA Eager To Avoid Replay Of CFC-To-HFA ‘Complexity’

The US FDA wants a smoother transition to newer “low global warming potential” propellants in metered dose inhalers than the prior transition away from CFCs.

The FDA wants the transition to "low global warming potential" metered dose inhaler propellants to have a minimal impact on patients. (Shutterstock)
Key Takeaways
  • The FDA hopes the transition away from HFA propellants in metered dose inhalers is not as complicated as the transition from CFC to HFA propellants.

The US Food and Drug Administration is planning to transition away from the hydrofluoroalkane (HFA) propellants currently used in metered...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Generics

More from Pathways & Standards